. /.   WORLD TRADE  
ORGANIZATION  G/TBT/N/CAN/191 
9 January 2007 
 (07-0084) 
Committee on Technical Barriers to Trade Original:   English/ 
 French 
 
 
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6. 
 
1. Member to Agreement notifying:   CANADA  
If applicable, name of local government involved (Articles 3.2 and 7.2):         
2. Agency responsible:   Department of Health 
Name and address (including telephone and fax numbers, e-mail and web-site 
addresses, if available) of  agency or authority designated to handle comments 
regarding the notification shall be  indicated if different from above:    
Canadian Enquiry Point 
200-270 Albert Street Ottawa, Ontario Canada, K1P 6N7 Tel.:  +1 613 238 3222 
Fax.: +1 613 569 7808 
E-mail: info@scc.ca 
3. Notified under Article 2.9.2 [  X ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:         
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading. 
ICS numbers may be provided in  addition, where applicable):    
Neotame (ICS:  67.040, 67.220) 
5. Title, number of pages and langua ge(s) of the notified document:   Proposed Amendment 
to the Food and Drug Regulations (1433 —  Neot ame) (5 pages, available in English and 
French). 
6. Description of content:   High intensity sweeteners used in the manufacture of foods are 
considered, under the Food and Drug Regulations , to be food additives. The high intensity 
sweeteners permitted under the Food and Drug Regulations are aspartame, sucralose and 
acesulfame-potassium.  
Health Canada has received a submission to  amend the Food and Drug Regulations to 
permit the use of neotame, a substance that is  7 000 to 13 000 times sweeter than sugar. 
Neotame would be used as a high intensity sw eetener in carbonated soft drinks, beverage 
concentrates, beverage mixes (powdered soft dr inks, pre-sweetened cocoa, or coffee mixes), 
unstandardized dairy beverages, unstandardi zed fruit juices, breakfast cereals, dessert 
mixes, toppings, topping mixes, fillings, f illing mixes, unstandardized desserts, yogurt, 
confectionery glazes for snack foods, sweetened  seasonings or coating mixes for snack 
foods, confections, including candies and thei r coatings, chewing gum, breath freshener 
products, unstandardized fruit spreads, pur ées, sauces, unstandardized table syrups, 
unstandardized salad dressings, peanut and ot her nut spreads, condiments, unstandardized 
baked goods, baking mixes, and as a table-t op sweetener at maximum levels of use 
specified in the proposed amendments.  G/TBT/N/CAN/191 
Page 2  
 
  Evaluation of available data supports the safet y and effectiveness of these uses of neotame.  
Under the current Regulations, all foods (includi ng those that are table-top sweeteners) that 
contain aspartame, acesulfame-potassium or sucralose must carry a statement on the principal display panel to the effect that the food contains or is sweetened with the 
sweetener. For foods carrying a nutrition facts table, the sweetener content expressed in milligrams per serving of stated size must be d eclared on their labels. In the case where the 
label of the food does not carry a nutrition f acts table, information on the energy value 
expressed in Calories or kilojoules, the protei n, fat, and carbohydrate content, expressed in 
grams per serving of stated size, and the sw eetener content expressed in milligrams per 
serving of stated size, must be provided on any part of the label, grouped with the list of 
ingredients. The same requirements are proposed for foods containing neotame.  
Therefore, it is the intention of Health Canada to recommend that the Food and Drug 
Regulations be amended to pe rmit the use of neotame in the above-named foods at the 
specified maximum levels of use and to require  that the label of a food containing neotame 
carries the information indicated above.  
This document has also been no tified under the SPS Agreement. 
7. Objective and rationale, including the na ture of urgent problems where applicable:  
Protection of human health 
8. Relevant documents:   Canada Gazette, Part I, 16 December 2006, Pages 4285-4299 
(Available in English and French) 
9. Proposed date of adoption:   
 
Proposed date of entry into force:    Normally within 5 to 8 months of publication 
in the Canada Gazette, Part I. 
On the date the measure is adopted 
10. Final date for comments:   1 March 2007 
11. Texts available from:  National enquiry point [  X ] or address, telephone and fax 
numbers, e-mail and web-site addresses, if available of the other body:   
The electronic version of the regulatory text can be downloaded at:  
http://canadagazette.gc.ca/partI/2006/20061216/pdf/g1-14050.pdf